Amarin Corp Plc (AMRN)

[zmanindc]

It was of all people Janet Woodcock who suggested to a few Epadi members we could OTC. That is the nuclear option, license OTC to J&J or P&G for royalties and sell the company. The buyer gets ROW plus a nice US royalty stream for a number of years and the generics get jack. Once it goes OTC insurance will not cover the generic brand. Vascepa has the patent and the FDA trial to market as the only drug when combined with a statin to reduce CVD risk.